Literature DB >> 2566253

The influence of 0.5% isoflurane on a vecuronium-induced neuromuscular blockade.

L I Eriksson1, P Staun, C Lennmarken.   

Abstract

The influence of adding 0.5% isoflurane to a narcotic-based anaesthesia on the duration of effect and recovery time after repetitive administration of vecuronium was studied in ten healthy patients. The twitch response in the adductor pollicis muscle was recorded after supramaximal train-of-four (TOF) stimulation of the ulnar nerve at the wrist. Prior to endotracheal intubation a bolus dose of vecuronium (0.08 mg/kg b.w.) was given. During surgery repeated injections of vecuronium (0.02 mg/kg b.w.) were administered at a TOF ratio of 0.25. Hand-skin temperature, systolic blood pressure, end-tidal CO2 and isoflurane concentrations were continuously monitored. Before and after 90 min administration of isoflurane, the duration of effect was 21 +/- 4 and 24 +/- 5 min (mean +/- s.d., P less than 0.05) respectively. Corresponding recovery times were 270 +/- 60 and 280 +/- 70 s (n.s.). Skin temperature remained unchanged and systolic blood pressure showed only minor variations. The addition of 0.5% isoflurane to a narcotic-based anaesthesia causes a moderate increase in duration of effect but no change in recovery time from a repetitive vecuronium-induced neuromuscular blockade of 0.02 mg/kg.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2566253     DOI: 10.1111/j.1399-6576.1989.tb02914.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  2 in total

1.  RETRACTED ARTICLE: Airway occlusion pressure is an indicator of respiratory depression with isoflurane.

Authors:  Y Fujii; H Tanaka; H Toyooka; K Amaha
Journal:  J Anesth       Date:  2006-12-31       Impact factor: 2.078

2.  Localized hypothermia influences assessment of recovery from vecuronium neuromuscular blockade.

Authors:  M L Young; C W Hanson; M J Bloom; J S Savino; S Muravchick
Journal:  Can J Anaesth       Date:  1994-12       Impact factor: 5.063

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.